Open Access · CC BY-NC-ND 4.0
Metabolic/Bariatric Surgery is Preferable to Incretin-Based Pharmacotherapy in Patients with Severe Obesity and CKD: PRO
Kidney360 · 04.06.2026
DOI: 10.34067/kid.0000001238 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney360, online erschienen am 04.06.2026. Verfasst von Allon N Friedman. Beteiligte Einrichtung: Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
ORCID-Profile: Allon N Friedman
Zitieren
APA
Friedman, A. N. (2026). Metabolic/Bariatric Surgery is Preferable to Incretin-Based Pharmacotherapy in Patients with Severe Obesity and CKD: PRO. Kidney360. https://doi.org/10.34067/kid.0000001238
Vancouver
Friedman AN. Metabolic/Bariatric Surgery is Preferable to Incretin-Based Pharmacotherapy in Patients with Severe Obesity and CKD: PRO. Kidney360. 2026. doi:10.34067/kid.0000001238
BibTeX
@article{Friedman2026,
author = {Friedman, Allon N},
title = {Metabolic/Bariatric Surgery is Preferable to Incretin-Based Pharmacotherapy in Patients with Severe Obesity and CKD: PRO},
journal = {Kidney360},
year = {2026},
doi = {10.34067/kid.0000001238}
}
EUVIMED